Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study)

  1. Martínez-Moragón, E.
  2. García-Moguel, I.
  3. Nuevo, J.
  4. Resler, G.
  5. Antépara, I.
  6. Arismendi-Núñez, E.
  7. Casas-Maldonado, F.
  8. Dávila-González, I.
  9. Velasco-Garrido, J.L.
  10. Díaz-Campos, R.
  11. Díaz-Donado, C.
  12. Gálvez, B.
  13. Izquierdo, J.L.
  14. López-Viña, A.
  15. Martínez-Moragón, E.
  16. Navarro-Soriano, C.
  17. Palop-Cervera, M.
  18. de Llano, L.P.
  19. Plaza, V.
  20. Racionero-Casero, M.Á.
  21. Rial-Prado, M.
  22. Rodríguez-Hernández, M.C.
  23. Rodríguez-Nieto, M.J.
  24. Zabaleta, M.
Journal:
BMC Pulmonary Medicine

ISSN: 1471-2466

Year of publication: 2021

Volume: 21

Issue: 1

Type: Article

DOI: 10.1186/S12890-021-01785-Z GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus